Fundraising Fox
TRIMTech Therapeutics
Cambridge, GB · Founded 2023 · 23 employees on LinkedIn · 7 known investors
Find your way into TRIMTech Therapeutics
Sign up to see every warm intro you have to TRIMTech Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TRIMTech Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.
Founders & leadership
TRIMTech Therapeutics was founded in 2023 by Damian Crowther, PhD FRCP, Dr. Leo James, and Dr. William McEwan.
Investors · 7
How we know: the company's own site · Cambridge Innovation Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: M Ventures's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Start Codon's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- TRIMTECH THERAPEUTICS LIMITED
- Company number
- 15299951
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 21 Nov 2023
- Registered office
- Suite D, Building 960 Babraham Research Campus, Cambridge, CB22 3FH
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 20 Nov 2025 · next due 4 Dec 2026
Current officers · 8
- Michael Leith Anstey — director, appointed 3 Dec 2024
- Laurence Daniel Paul Barker — director, appointed 3 Dec 2024
- Lucy Charlotte Edwardes Jones — director, appointed 24 Jun 2026
- Hakan Goker — director, appointed 19 Feb 2025
- Nadiya Ishnazarova — director, appointed 24 Jun 2026
- Alison Frances Lawton — director, appointed 20 Nov 2025
- Marie-Claire Peakman — director, appointed 19 Feb 2025
- Nicola Thompson — director, appointed 27 Feb 2024
Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does TRIMTech Therapeutics do?
- TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.
- Who founded TRIMTech Therapeutics?
- TRIMTech Therapeutics was founded by Damian Crowther, PhD FRCP, Dr. Leo James, Dr. William McEwan in 2023.
- Who are TRIMTech Therapeutics's investors?
- TRIMTech Therapeutics's investors include Cambridge Innovation Capital, Pfizer Ventures, SV Health Investors, M Ventures, Pfizer Venture Investments, Start Codon, Diamond Edge Ventures.
- Where is TRIMTech Therapeutics headquartered?
- TRIMTech Therapeutics is headquartered in Cambridge, GB.